Maravai LifeSciences MRVI
Valuation
Multiples measured against the stock's own five-year history
Near the bottom of its 5-year range · 0th percentile, 5-year average 3.5x
Near the top of its 5-year range · 81st percentile, 5-year average 4.4x
#4525 of 5329 stocks by PB (1 = cheapest)
Near the top of its 5-year range · 89th percentile, 5-year average 3.2x
#3989 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 5.75 | – | 4.36 | 81% (pricier than usual) | #4525 of 5329 (1 = cheapest) |
| PE | -17.14 | -23.14 | 3.54 | 0% (cheaper than usual) | – |
| PS | 5.28 | 5.12 | 3.23 | 89% (pricier than usual) | #3989 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on MRVI.
Sign in to join the discussion.